Uk Mhra Gmp
ALMAC SCIENCES LIMITEDALMAC SCIENCES LIMITED – UK MHRA GMP Certificate UK API 31890 Insp GMP 31890/383321-0016
Record Details
This Uk Mhra Gmp record concerns ALMAC SCIENCES LIMITED, with an inspection on December 16, 2019, issued by the MHRA, covering drugs.
- Company
- ALMAC SCIENCES LIMITED
- Compliance status
- GMPC
- Certificate type
- GMP
- Inspection date
- December 16, 2019
- Issued
- October 15, 2021
- MIA number
- UK API 31890
- Site address
- ALMAC HOUSE, 20 SEAGOE INDUSTRIAL ESTATE, CRAIGAVON, BT63 5QD, UNITED KINGDOM
- Country
- UNITED KINGDOM
- Products
- Human Medicinal Products
- Manufacturing operations
- [2000017443] URIDINE TRIACETATE [3000017276] SELEXIPAG [1000018046] ACTIVE SUBSTANCES FOR CLINICAL TRIALS [2000018682] AMIFAMPRIDINE PHOSPHATE Active Substances 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES URIDINE TRIACETATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.2 Manufacture Of Crude Active Substance 3.1.3 Salt Formation/Purification steps (eg. Crystallisation) crystallisation 3.5 General Finishing Steps 3.5.2 Primary Packaging 3.5.3 Secondary Packaging 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing SELEXIPAG 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1 Manufacture Of Active Substance Intermediates 3.1.2 Manufacture Of Crude Active Substance 3.1.3 Salt Formation/Purification steps (eg. Crystallisation) crystallisation 3.5 General Finishing Steps 3.5.1 Physical Processing Steps micronisation 3.5.2 Primary Packaging 3.5.3 Secondary Packaging 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing ACTIVE SUBSTANCES FOR CLINICAL TRIALS 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1 Manufacture Of Active Substance Intermediates Radiopharmaceuticals 3.1.2 Manufacture Of Crude Active Substance Radiopharmaceuticals 3.1.3 Salt Formation/Purification steps (eg. Crystallisation) crystallisation, distillation, chromatography or similar alternatives Radiopharmaceuticals 3.5 General Finishing Steps 3.5.1 Physical Processing Steps micronisation 3.5.2 Primary Packaging Radiopharmaceuticals 3.5.3 Secondary Packaging Radiopharmaceuticals 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing Radiopharmaceuticals AMIFAMPRIDINE PHOSPHATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1 Manufacture Of Active Substance Intermediates 3.1.2 Manufacture Of Crude Active Substance 3.1.3 Salt Formation/Purification steps (eg. Crystallisation) crystallisation 3.5 General Finishing Steps 3.5.2 Primary Packaging 3.5.3 Secondary Packaging 3.6 Quality Control Testing 3.6.1 Physical / Chemical testing 3.6.2 Microbiological testing (excluding sterility testing)
View Company Profile
ID · c478e671-210a-4596-bed3-ebce54735996
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.